Results 151 to 160 of about 52,798 (213)

Towards a Standard Protocol for Fecal Microbiota Transplantation in Irritable Bowel Syndrome. [PDF]

J Neurogastroenterol Motil
El-Salhy M, Corsetti M, Gilja OH, Gonlachanvit S, Hatlebakk JG, Hoff DAL, Lahtinen P, Lunding JA, Mazzawi T, Monaghan TM, Ohlsson B, Patcharatrakul T, Kim YS, Shin CM.   +13 more
europepmc   +1 more source

Age‐related long‐term effects of vaginal delivery, pregnancy, and sphincter injury on anal continence: A matched cohort study

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 7, Page 1221-1229, July 2026.
Long‐term fecal incontinence was more common and severe after two vaginal deliveries and twice as high following obstetric anal sphincter injury. An age‐related increase in fecal incontinence appeared after two vaginal deliveries but was not observed after cesarean delivery or in nulliparas.
Ida E. K. Nilsson, Jwan Al‐Mukhtar Othman, Jennie Larsudd‐Kåverud, Sigvard Åkervall, Mattias Molin, Ian Milsom, Maria Gyhagen   +6 more
wiley   +1 more source

Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations. [PDF]

J Am Assoc Nurse Pract
Ladewski AM, Orleck KD, Skarbinski KF.
europepmc   +1 more source

Three‐dimensional endoanal ultrasound measurements for the assessment of perineal body size in a cohort of Swedish nulligravidae

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 7, Page 1303-1308, July 2026.
We provide normative data on perineal body dimensions in nulliparous women using high‐resolution 3D ultrasound. These findings enhance anatomical understanding and may support clinical assessment of perineal integrity in women. Abstract Introduction Despite the perineal body's important functional role, few studies have specifically evaluated its size ...
Emilia Rotstein, Nina Rose, Marianne Starck, Hedvig Engberg   +3 more
wiley   +1 more source

Residential green space mitigates genetic susceptibility to incident irritable bowel syndrome in a prospective cohort of 376 749 individuals. [PDF]

J Glob Health
Kou Z, Li R, Wang J, Shao Z, Feng J, Wei M, Fu T, Chen L, Zheng G, Lin H, Liu K.   +10 more
europepmc   +1 more source

Supporting Children With a Chronic Disease and Their Parents When Admitted to Hospital: A Scoping Review of Psychosocial Supports

Acta Paediatrica, Volume 115, Issue 7, Page 1322-1372, July 2026.
Importance of psychosocial support. ABSTRACT Aim The aim of this scoping review was to identify, examine, and summarize available evidence regarding psychosocial supports provided to children with a chronic disease when admitted to hospital and their parents. Method The JBI methodology for conducting and reporting scoping reviews was followed.
Lyndsay Jerusha MacKay, Nolan Lagrisolal, Una Chang, Matthew Christoffersen, K. Alix Hayden, Kathryn Birnie, Tammie Dewan   +6 more
wiley   +1 more source

Gut Virome: What's the Role in Irritable Bowel Syndrome? [PDF]

Rev Med Virol
Rettura F, Lambiase C, Bottari A, Filippini F, Giacomelli L, Pistello M, Bellini M.   +6 more
europepmc   +1 more source

The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 2, Page 208-221, July 2026.
In a cohort of IBS‐D patients recruited to the TRITON study, faecal metabolomic profiling reveals a SCFA‐enriched metabotype associated with increased pain and urgency, altered stool characteristics and accelerated intestinal transit. ABSTRACT Background Metabolomic analysis in irritable bowel syndrome (IBS) has identified metabotypes enriched in ...
T. E. Conley, A. Duncan, A. Modasia, A. C. Ford, D. M. Pritchard, F. Hildebrand, F. J. Warren, R. Spiller, C. S. Probert   +8 more
wiley   +1 more source

From Belief to Behavior: Closing the Knowledge-Practice Gap in Irritable Bowel Syndrome Self-management. [PDF]

J Neurogastroenterol Motil
Kim JW.
europepmc   +1 more source

Psilocybin as a novel treatment for chronic pain

British Journal of Pharmacology, Volume 183, Issue 14, Page 3992-4005, July 2026.
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey, Reena Lasrado, Maria Maiarú, Gary J. Stephens   +3 more
wiley   +1 more source